Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Feb 19.
Published in final edited form as: Sex Transm Infect. 2014 May 29;90(8):620–626. doi: 10.1136/sextrans-2014-051548

Prevalence of HIV, HSV-2 and pregnancy amongst high school students in rural KwaZulu-Natal: a bio-behavioral cross-sectional survey

ABDOOL KARIM Quarraisha 1,2,§, BM KHARSANY Ayesha 1, LEASK Kerry 1, NTOMBELA Fanelisibonge 1, HUMPHRIES Hilton 1, A FROHLICH Janet 1, SAMSUNDER Natasha 1, GROBLER Anneke 1, DELLAR Rachael 1, ABDOOL KARIM Salim 1,2
PMCID: PMC4759648  NIHMSID: NIHMS759491  PMID: 24873967

Abstract

Objective

Adolescents in southern African high schools are a key population for HIV prevention interventions. We report on the prevalence of HIV, HSV-2, and pregnancy as indicators of high risk sexual behavior amongst high school students in rural KwaZulu-Natal.

Design

Bio-behavioral cross-sectional survey

Methods

Students completed a self-administered structured, standardized demographic and sexual behavioral questionnaire. Dried blood spot specimens were collected for HIV and HSV-2 testing. Urine specimens were used for pregnancy testing in female students.

Results

A total of 2675 (1423 females, 1252 males) consenting students were enrolled from 14 high schools between September and November 2010. The median age of students was 16 years [interquartile range (IQR) 15–18]. HIV prevalence was 1.4% (95% CI 0.9–1.9) in males and 6.4% (95% CI 4.6–8.3) in females (p < 0.001). HSV-2 prevalence was 2.6% (95% CI 1.6–3.7) in males and 10.7% (95% CI 8.8–12.6) in females (p < 0.001). Pregnancy prevalence was 3.6% (95% CI 2.6–4.5). Risk factors for prevalent HIV infection in female students included being over 18 years of age [adjusted odds ratio (aOR)=2.67, 95% CI 1.67–4.27; p<0.001], prevalent HSV-2 infection (aOR=4.35, 95% CI 2.61–7.24; p<0.001), previous pregnancy (aOR=1.66, 95%CI 1.10–2.51; p=0.016) and experience of two or more deaths in the household in the previous year (aOR=1.97, 95% CI 1.13–3.44; p=0.016).

Conclusions

The high prevalence of HIV, HSV-2 and pregnancy underscore the need for school-based sexual and reproductive health services, and provide further impetus for the inclusion of adolescents in behavioral and biomedical trials with HIV incidence endpoints.

Keywords: HIV, HSV-2, pregnancy prevalence, students, high schools, rural KwaZulu-Natal

INTRODUCTION

The South African province of KwaZulu-Natal is at the global epicenter of the human immunodeficiency virus (HIV) epidemic, with an estimated 1.7 million people in the province living with HIV (1,2). Such high population prevalence is fuelled by unprecedentedly high incidence rates, particularly in young people aged 15–24 years in whom HIV prevalence in KwaZulu-Natal was estimated at 12% in 2012 (1,3). Moreover, in South Africa, nearly a third of all new HIV infections occur in 15–24 year olds (1), with young women in this age group being five to six times more likely to be infected than their male peers (4,5), underscoring the importance of adolescents –particularly adolescent girls- as a priority group for evidence-based HIV prevention interventions (6).

High risk behavior during adolescence is generally associated with unfavorable health outcomes, including HIV acquisition (7). Priority adolescent-targeted HIV prevention efforts should therefore include risk reduction information to increase young people’s awareness and knowledge of HIV/AIDS during the early formative years. Numerous HIV prevention initiatives and campaigns for young people with these aims are being implemented (813). Whilst these programmes are active in many schools and communities and have contributed to increasing awareness of HIV/AIDS, evidence-based behaviour change interventions that prevent HIV infection in adolescents remain rare (8, 1416). Nonetheless, given almost three quarters of South Africans aged 7–24 years attend schools (17), schools have the potential to be important and convenient venues for HIV prevention interventions.

In this paper, we describe the demographic and biological characteristics of high school students in rural KwaZulu-Natal, with the aim of quantifying the magnitude of HIV infection and sexual risk in high schools to inform the development of school-based HIV prevention interventions.

METHODS

Study Setting and Population

The study was conducted in Vulindlela, a rural sub-district of KwaZulu-Natal characterized by limited infrastructure, poverty and high rates of HIV infection (18). Fourteen out of a total of 42 high schools in the district were included in this study. Selection of schools was based on criteria which included a minimum of 150 enrolled students, grade 12 exam pass rates, ease of physical access to schools, and school principal acceptance of the survey. All students in grades 9 and 10 of selected schools, regardless of age, gender or HIV status, were eligible for inclusion. Students were recruited following extensive community consultation. First person consent was obtained from students ≥18 years following a literacy and comprehension assessment. For students <18 years, assent was obtained from the student and consent from the parent/guardian. If a parent or guardian was unavailable (due to migrant labor, illness or death), the participation of the relevant student was assessed by a representative of the School Research Support Group (SRSG) who provided proxy parental consent.

Study Design and Methods

This cross-sectional bio-behavioral study was undertaken between September and November 2010. Demographic and behavioral characteristics of participants were assessed using self-reported, standardized, structured questionnaires. Names of participants were collected as identifying information to facilitate follow-up care if later required. Field staff maintained a secure database that had the unique study number and name, school and grade of enrolled students. A delinked database using the unique study number was utilized for data analysis purposes. Students completed self-administered questionnaires facilitated by study staff; students were able to choose between English or isiZulu for the preferred language of this questionnaire.

HIV testing was performed using HIV ELISA from Vironostika Uniform 11 plus O Assay, Biomerieux, (Netherlands). All samples testing HIV positive were further confirmed with the SD Bioline HIV-1/2 ELISA 3.0 kit (SD Standard Diagnostics, INC. Korea). HSV-2 testing was performed using HerpeSelect® HSV-2 ELISA Kits (Focus Diagnostics, California, USA) for the qualitative detection of human IgG class antibodies to HSV-2 based on recombinant gG2; this method for detection has been validated for use on dried blood spots (8, 16, 19). Urine pregnancy testing was performed using the QuickVue One-Step hCG Urine Test (Quidel Corporation, San Diego, USA). Group pre-test counseling was provided to all learners prior to specimen collection. .

Follow-up care

On completion of laboratory testing, students were invited to attend their local primary health care clinic to access results from study staff in the context of individual pre- and post-test counselling. Students found to be HIV positive, pregnant or requiring additional care, were referred for further care within the clinic, or had the option of referral to the adolescent-friendly services at the CAPRISA Vulindlela Clinic for free care and treatment, including provision of antiretrovirals. Students in need of psychosocial support were referred to a local experienced non-government organization, Zimnande Zonke.

In the case that a student was found to be HIV positive or pregnant and failed to collect their results, they were pro-actively followed up through a process designed to ensure confidentiality and minimize stigma and discrimination by including HIV negative and non-pregnant learners in interviews with the stated aim of validation of biological and behavioral assessments. This process excluded learners who tested HSV-2 positive because the South African Department of Health Guidelines for management of sexually transmitted diseases was used, which is based on syndromic management rather than diagnostic testing. Throughout the follow-up process, confidentiality and minimization of stigma and discrimination was respected to the extent permitted by Section 13(1)(d) of the Children’s Act of 2005 (20).

Data management

All self-reported data were collected on standardized case report forms (CRFs) using the student’s unique study number and faxed using DataFax (Clinical DataFax Systems Inc., Hamilton, Canada). All laboratory data were linked to the questionnaire data using the student’s unique identification number.

Statistical analysis

The demographic, behavioral and biological characteristics were summarized using descriptive summary measures, expressed as means [±standard deviation (±SD)] and/or medians [with interquartile range (IQR)] for continuous variables and percentages for categorical variables. In order to adjust for cluster effects inherent in school-based sampling, cluster level summaries were computed. In the adjusted analysis prevalence was calculated in each cluster and these cluster level prevalence estimates were then averaged by gender. The unadjusted analysis ignored the clustering and merely calculated the prevalence by combining all clusters. The estimates of prevalence calculated from each of the 14 clusters were compared by gender using t-tests for two independent samples as described in Hayes and Moulton (21). A multivariate analysis was performed to explore risk factors for HIV and HSV-2 infection in female students and overall. Univariate and multivariate adjusted odds ratios (aOR) were calculated with 95% confidence intervals (CI) using generalized linear mixed models with a logit link modelling the probability of being infected and including a random effect for school. The SAS statistical package (version 9.3; Statistical Analysis Software, North Carolina, USA) was used for the analysis.

Ethical approval

The protocol, self-administered questionnaires, informed consent forms and study related materials were reviewed and approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee (reference number B105/010).

RESULTS

The total grade 9 and 10 school student population in the 14 schools sampled was 3781. A total of 2675 (70.7%) students provided consent or assent with parent or guardian consent and were enrolled in the study. Of these, 1423 (53.2%) were females and 1252 (46.8%) were males. The most common reason for non-enrollment was parental refusal of consent (653/1106, 59.0%); a small proportion of students had insufficient cognitive ability to provide consent/assent (2/1106, 0.2%).

Demographic and behavioral characteristics

The demographic and selected behavioral characteristics of students are presented in Table 1. The overall median age of students was 16 years (IQR 15–18), with a median age of 17 years (IQR 16–18) for males and 16 years (IQR 15–17) for females (p<0.001). Substantial proportions (18.2% of males, 11.0% of females) of students were over 18 years of age. The age range of students was wide at 12–28 years for males, and 13–24 years for females. A significant proportion of students (43.0% of males, 47% of females) had experienced at least one death in the household in the last year, potentially contributing to the low percentages of students in households headed by both parents (16.9% of males, 20.1% of females). Moreover, in this setting, as marriage is rare, it is common for students to be living in female-headed households (33.1% of males, 32.1% of females).

Table 1.

Demographics and behavioral characteristics of students in rural KwaZulu-Natal, South Africa.

Characteristic Males (N=1252) Females (N=1423) Adjusted#
P-value
Unadjusted
% (n/N)
Adjusted#
%
Unadjusted
% (n/N)
Adjusted#
%
Demographic Characteristics
Age Median (IQR) 17 (16–18) years 16 (15–17) years <0.001
Age Range 12–28 years 13–24 years
Age category
 ≤ 15 years 23.7(297) 25.6 41.5(591) 41.6 0.002
 16–17 years 40.3(505) 40.4 37.7(537) 37.5 0.383
 18–19 years 27.5(344) 26.0 14.9(212) 14.8 0.005
 ≥20 years 8.5(106) 8.0 5.8(83) 6.1 0.518
Head of household
 Both parents 16.9 (210/1240) 16.9 20.1 (283/1411) 20.1 0.210
 Father only 16.9 (210/1240) 17.2 15.7 (222/1411) 15.6 0.241
 Mother only 33.1 (410/1240) 33.2 32.4 (457/1411) 32.1 0.613
 Other 33.1 (410/1240) 32.7 31.8 (449/1411) 32.1 0.838
Adult deaths in household in last year
 0 57.5 (709/1234) 57.0 53.4 (751/1406) 53.0 0.137
 1 18.3 (226/1234) 18.6 20.3 (285/1406) 20.2 0.311
 >1 24.2 (299/1234) 24.4 26.3 (370/1406) 26.9 0.399
Grade
 Grade 9 45.9(572) 45.6 49.2(699) 47.9 0.575
 Grade 10 54.1(675) 54.4 50.8(722) 52.1 0.575
Behavioral Characteristics
 Experience of penovaginal sex 34.8(429/1232) 33.1 21.9(307/1399) 21.6 0.009
 Age at coital debut (Median, IQR); (N) 15 (14–17) years; (423) 16 (15–17) years; (293) <0.001
 Threat of violence for sex 6.7 (83/1234) 6.7 6.8 (95/1406) 6.9 0.924
Partner Characteristics
 Younger partner 24.4 (119/487) 26.8 9.0 (28/311) 10.8 <0.001
 Same age partner 22.2 (108/487) 22.4 9.0 (28/311) 9.7 <0.001
 <4 years older 39.2 (191/487) 38.0 43.4 (135/311) 43.1 0.177
 4–7 years older 11.3 (55/487) 10.0 32.8 (102/311) 31.5 <0.001
 ≥8 years older 2.9 (14/487) 2.9 5.8 (18/311) 4.9 0.304
#

Adjusted measures were calculated based on cluster(school)-level summaries appropriate for school-based sampling; for those variables where there were missing observations, the total number of observations (N) is shown.

The median age of coital debut for those students that had ever had sex was 15 (IQR 14–17) years for males compared to 16 (IQR 15–17) years for females (p<0.001), and compared to females more males reported ever being sexually active (33.1% males versus 21.6% females; p=0.01). Self-reported experience or threat of violence to have sex was 6.7% for males and 6.9% for females (p=0.92). Males were significantly more likely to have a sexual partner of their own age or younger compared to females (p<0.001). More than one in three sexually active females reported having a sexual partner at least four years their senior.

Prevalence of HIV, HSV-2, and pregnancy

The prevalence of HIV and HSV-2 students stratified by gender and age are presented in Table 2. The HIV prevalence was 1.4% (95% CI 0.9–1.9) in males and 6.4% (95% CI 4.6–8.3) in females (p<0.001). In males, HIV prevalence remained low (~1%) in those below 18 years of age and increased steadily thereafter with increasing age. In contrast, a substantial proportion of females were HIV infected by age 18 years, with risk of infection increasing rapidly from age 15 years; by age 20, one in four females were HIV infected. The overall HIV prevalence varied between 1.9% (95% CI 0.0–4.0) to 8.3% (95% CI 4.0–12.7) in the 14 schools included in the survey.

Table 2.

HIV, HSV-2 and pregnancy prevalence by age group among students in rural KwaZulu-Natal, South Africa

Characteristic Males (n=1252) Females (n=1423) Adjusted#
P-value
Unadjusted
% (n/N)
Adjusted#
%
Unadjusted
% (n/N)
Adjusted#
%
HIV Prevalence*
Overall 1.4 (18/1252) 1.4 6.2 (88/1423) 6.4 <0.001
Age category
 ≤ 15 years 1.4 (4/297) 1.0 2.7 (16/591) 2.6 0.063
 16–17 years 1.2 (6/505) 1.1 5.4 (29/537) 6.1 0.006
 18–19 years 0.9 (3/344) 1.5 11.3 (24/212) 13.6 <0.001
 ≥ 20 years 4.7 (5/106) 1.8 22.9 (19/83) 24.7 0.010
HSV-2 Prevalence*
Overall 3.0 (38/1252) 2.6 10.4 (148/1423) 10.7 <0.001
Age category
 ≤15 years 0.7 (2/297) 0.7 4.1 (24/590) 3.5 0.006
 16–17 years 2.0 (10/505) 2.0 8.6 (46/537) 9.3 0.001
 18–19 years 6.1 (21/344) 6.6 22.6 (48/212) 30.2 0.002
 ≥ 20 years 4.7 (5/106) 3.5 36.1 (30/83) 43.3 0.001
Pregnancy Prevalence*
Overall Not applicable 3.5 (49/1412) 3.6 Not applicable
Age category
 ≤ 15 years 1.7 (10/587) 1.9
 16–17 years 3.8 (20/533) 4.2
 18–19 years 7.2 (15/209) 6.2
 ≥ 20 years 4.8 (4/83) 3.6
*

Missing observations excluded from percentage calculations

#

Adjusted measures were calculated based on cluster(school)-level summaries appropriate for school-based sampling

Variability was also observed in HSV-2 prevalence between schools, which ranged from 2.5% (95% CI 0.1–5.0) to 9.6% (95% CI 4.2–14.9). HSV-2 prevalence was 2.6% (95% CI, 1.6–3.7) in males and 10.7% (95% CI 8.8–12.6) in females (p< 0.001). In both sexes, prevalence of HSV-2 infection increased rapidly from age 15 years, such that acquisition of HSV-2 infection was synonymous with sexual debut. Similar to the age-sex disparity in HIV prevalence, females had a consistently three to four fold higher prevalence of HSV-2 across most age groups and were observed to bear a disproportionate burden of HSV-2 infection compared to males.

The overall pregnancy prevalence was 3.6% (95% CI 2.6–4.5). Pregnancy prevalence was highest in females aged 18–19 years (7.2%). As with HIV and HSV-2 prevalence, pregnancy prevalence varied between 0.9% (95% CI 0.0–2.7) to 5.7% (95% CI 2.1–9.4) across schools.

Risk factors associated with prevalence of HIV, HSV-2, and pregnancy

A multivariate analysis was performed to adjust for confounding and to explore risk factors associated with prevalence of HIV, HSV-2 and pregnancy in high school students (Supplementary Table 1). This analysis confirmed that compared to their male peers, female students face substantially higher burdens of both HIV (aOR=4.49, 95% CI 2.94–6.88; p<0.001) and HSV-2 (aOR=4.66, 95% CI 3.16–6.87; p<0.001). As such, a further multivariate analysis was performed on female students to avoid dilution of any associations, and to better inform future interventions targeted to this priority population by identification of female-specific risk factors of HIV, HSV-2 and pregnancy (Table 3).

Table 3.

Risk factors associated with prevalent HIV and HSV-2 infection in female students

Univariate analysis Multivariate analysis
Characteristic % (n/N) Odds Ratio (95% CI) p-value Odds Ratio (95% CI) p-value
HIV
Age < 18 years 18.9% (252/1335) 1.00 (reference) 1.00 (reference)
≥ 18 years 48.9% (43/88) 4.15 (2.93 – 5.88) <0.001 2.67 (1.67 – 4.27) <0.001
Pregnant Negative 6.2% (84/1363) 1.00 (reference) 1.00 (reference)
Positive 6.1% (3/49) 0.97 (0.29 – 3.19) 0.959 0.64 (0.17 – 2.73) 0.551
HSV-2 Negative 4.3% (55/1274) 1.00 (reference) 1.00 (reference)
Positive 22.3% (33/148) 6.32 (3.94 – 10.14) <0.001 4.35 (2.61 – 7.24) <.001
Head of household Both parents 6.8% (15/222) 1.00 (reference) 1.00 (reference)
Father only 5% (23/457) 1.45 (0.68 – 3.06) 0.337 1.26 (0.59 – 2.73) 0.551
Mother only 5% (14/283) 1.04 (0.53 – 2.06) 0.905 0.82 (0.38 – 1.79) 0.621
Other 8% (36/449) 1.73 (0.92 – 3.28) 0.091 1.80 (0.93 – 3.49) 0.082
Adult deaths in household in last year 0 4.5% (34/751) 1.00 (reference) 1.00 (reference)
1 6% (17/285) 1.37 (0.75 – 2.49) 0.309 1.30 (0.65 – 2.58) 0.455
> 1 10% (37/370) 2.37 (1.46 – 3.85) 0.001 1.97 (1.13 – 3.44) 0.016
Ever been pregnant No 5% (63/1258) 1.00 (reference) 1.00 (reference)
Yes 17% (25/147) 3.89 (2.36 – 6.41) <.001 1.66 (1.10 – 2.51) 0.016
Relative partner age* Peers or younger 14.7% (28/191) 1.00 (reference)
≥ 4 years older 11.7% (14/120) 0.77 (0.42 – 1.41) 0.403
Threat of violence No 6.0% (78/1311) 1.00 (reference) 1.00 (reference)
Yes 10.5% (10/95) 1.72 (0.92 – 3.22) 0.090 1.09 (0.76 – 1.57) 0.645
HSV-2
Age < 18 years 17.0% (217/1274) 1.00 (reference) 1.00 (reference)
≥ 18 years 52.7% (78/148) 5.39 (4.00 – 7.27) <0.001 3.20 (2.33 – 4.38) <0.001
Pregnant Negative 6.2% (84/1363) 1.00 (reference) 1.00 (reference)
Positive 6.1% (3/49) 0.97 (0.29 – 3.19) 0.959 1.37 (0.63 – 2.97) 0.425
HIV Negative 4.3% (55/1274) 1.00 (reference) 1.00 (reference)
Positive 22.3% (33/148) 6.32 (3.94 – 10.14) <0.001 4.34 (2.64 – 7.13) <.001
Head of household Both parents 6.8% (15/222) 1.00 (reference) 1.00 (reference)
Father only 5% (23/457) 1.45 (0.68 – 3.06) 0.337 1.12 (0.59 – 2.11) 0.737
Mother only 5% (14/283) 1.04 (0.53 – 2.06) 0.905 1.68 (1.02 – 2.75) 0.041
Other 8% (36/449) 1.73 (0.92 – 3.28) 0.091 1.16 (0.65 – 2.10) 0.615
Adult deaths in household in last year 0 4.5% (34/751) 1.00 (reference) 1.00 (reference)
1 6% (17/285) 1.37 (0.75 – 2.49) 0.309 1.41 (0.92 – 2.14) 0.112
> 1 10% (37/370) 2.37 (1.46 – 3.85) 0.001 1.13 (0.70 – 1.83) 0.618
Ever been pregnant No 5% (63/1258) 1.00 (reference) 1.00 (reference)
Yes 17% (25/147) 3.89 (2.36 – 6.41) <0.001 2.52 (1.58 – 4.03) <0.001
Relative partner age* Peers or younger 24.6 (47/191) 1.00 (reference)
4–7 years older 25.8 (31/120) 1.05 (0.71 – 1.55) 0.799
Threat of violence No 9.5 (125/1311) 1.00 (reference) 1.00 (reference)
Yes 22.3 (21/94) 2.34 (1.55 – 3.54) <0.001 1.95 (1.30 – 2.95) 0.001
Pregnancy
Age < 18 years 20.0% (273/1363) 1.00 (reference) 1.00 (reference)
≥ 18 years 38.8% (19/49) 2.68 (1.75 – 4.11) <0.001 2.27 (1.22 – 4.23) 0.010
HIV Negative 3.5% (46/1319) 1.00 (reference) 1.00 (reference)
Positive 3.5% (3/87) 1.00 (0.27 – 3.74) 0.995 0.58 (0.16 – 2.18) 0.422
HSV-2 Negative 3.2% (40/1258) 1.00 (reference) 1.00 (reference)
Positive 6.1% (9/147) 1.98 (0.88 – 4.49) 0.100 1.22 (0.52 – 2.88) 0.645
Head of household Both parents 2.9% (8/280) 1.00 (reference) 1.00 (reference)
Father only 3.2% (7/219) 1.17 (0.51 – 2.70) 0.714 1.08 (0.45 – 2.58) 0.863
Mother only 4.2% (19/451) 1.56 (0.65 – 3.75) 0.316 1.37 (0.54 – 3.47) 0.513
Other 3.4% (15/444) 1.24 (0.46 – 3.30) 0.671 1.21 (0.44 – 3.32) 0.713
Adult deaths in household in last year 0 2.3% (17/742) 1.00 (reference) 1.00 (reference)
1 5.3% (15/282) 2.45 (1.20 – 5.00) 0.014 2.28 (1.17 – 4.43) 0.015
> 1 4.6% (17/366) 2.12 (1.11 – 4.05) 0.022 1.78 (0.91 – 3.48) 0.091
Ever been pregnant No 3.1% (38/1242) 1.00 (reference) 1.00 (reference)
Yes 7.5% (11/146) 2.72 (1.59 – 4.65) <0.001 1.61 (0.79 – 3.28) 0.187
Relative partner* age Peers or younger 8.4% (16/191) 1.00 (reference)
≥ 4 years older 6.8% (8/118) 0.8 (0.42 – 1.51) 0.4835
Threat of violence for sex No 3.4% (44/1302) 1.00 (reference) 1.00 (reference)
Yes 5.4% (5/93) 1.61 (0.88 – 2.95) 0.1189 1.17 (0.6 – 2.27) 0.647
*

Relative partner age could not be included in the multivariate analysis because of the high frequency of missing data for this variable.

Those female students who were aged over 18 years (aOR=2.67, 95% CI 1.67–4.27), were HSV-2 seropositive (aOR=4.35, 95% CI 2.61–7.24; p<0.001), had previously been pregnant (aOR=1.66, 95% CI 1.10–2.51; p=0.016), and had experienced more than one death in their household (aOR=1.97, 95% CI 1.13–3.44; p=0.016) were all identified to be at significantly increased risk of HIV infection. A marginal association with prevalent HIV infection was observed in those female students who were from households headed by an individual who was not a parent. No additional risk factors were identified in the multivariate analysis performed on all students.

Significant risk factors for HSV-2 in female students were identified as age greater than 18 years (aOR=3.20, 95% CI 2.33–4.38; p<0.001), HIV positive serostatus (aOR=4.34, 95% CI 2.64–7.13; p<0.001), previous pregnancy (aOR=2.52, 95% CI 1.58–4.03; p<0.001), experience of threat of violence for sex (aOR=1.95, 95% CI 1.30–2.95; p=0.001) and living in a female-headed household (aOR=1.68, 95% CI 1.02–2.75; p=0.041). In the multivariate analysis performed on all students, experience of an adult death in the household was also identified as a risk factor for HSV-2 positive serostatus (aOR=1.36, 95% CI 1.02–1.81; p=0.036).

Experience of an adult death in the household was also identified as a risk factor for pregnancy in female students (aOR=2.27, 95% CI 1.22–4.23; p=0.010), together with being over 18 years of age (aOR=2.28, 95% CI 1.17–4.43; p=0.015).

DISCUSSION

High school students in this setting already bear a substantial burden of HIV, HSV-2 and pregnancy that correlates with self-reported high risk sexual activity. These data provide further impetus for targeting sexual reproductive health services and evidence based HIV prevention interventions to the adolescent population in high HIV burden settings.

This comprehensive report of such high HIV prevalence in a school-based population is novel, however the data presented are consistent with other smaller scale school based surveys in the region in similar age groups (4), underscoring the current inadequacies of HIV prevention efforts for school based adolescents. Similarly, this is the first description in high school students of the age-sex disparity in HIV acquisition that defines the HIV epidemic in sub-Saharan Africa (1, 22). We found HIV acquisition to be almost synonymous with sexual debut in female students. To inform the design of appropriate interventions to address these issues, the poor internalization of HIV risk in this setting, as well as the social factors such as threats of violence for sex and adult deaths in the household that inflate the HIV risk in this population, all need to be better understood.

Whilst high school completion rates are associated with lower HIV risk (23, 24), teenage pregnancies too commonly lead to school drop-out and perpetuate a cycle of poverty, dependency and risk taking for survival (25). The high teenage pregnancy rates reported in this study are a cause for concern- particularly concerning the identification of previous pregnancy as a risk factor for HIV and HSV-2 infection- and underscore the urgent need for targeted information sessions for these students on outcomes of sexual activity and enhancing access to sexual reproductive health services.

The wide age range of both male and female students in grades 9 and 10 in these schools result in children and adults being educated simultaneously, and potentially contributes to precocious sexual behaviors in younger students. Separation of schooling of children from adults is a simple intervention that could be easily and immediately implemented to create a supportive environment for HIV risk reduction and enhance female school completion rates.

This study highlights a huge degree of variability in HIV, HSV-2 and pregnancy prevalence between schools; while elucidating the causes for such variability will be informative, this variability also has important implications for the design of trials to establish the efficacy of interventions to prevent HIV infection in high HIV burden settings.

Given that positive HSV-2 serostatus is recognized as an important risk factor for HIV acquisition (26) and that in this setting it was found to increase the risk of HIV infection almost four-fold in female students, the high HSV-2 prevalence in both male and female students in these high school students is concerning and could be an important contributor to the already high burden of HIV in this school based population and in the wider community. Thus, HSV-2 prevention efforts should also aim to reach adolescents, and in particular adolescent girls. The results of the CAPRISA 004 tenofovir gel trial, demonstrating an overall effectiveness of 39% for HIV acquisition prevention and 51% for HSV-2 acquisition prevention in urban and rural women over 18 years, could have relevance for this adolescent school population (27,28). However, tenofovir gel lacks safety assessments in this age group which will be required as a precursor to implementation of any biomedical intervention.

Our school-based data is consistent with population-level surveys in similar age groups, which may be explained by the high proportion of adolescents in high schools in South Africa in the selected grades, and suggests that school-based surveys may be an important and generalizable tool in monitoring the evolving HIV epidemic (1,29). Moreover, any potential bias introduced by inclusion criteria for school selection appears to have had limited impact on our findings, possibly due to the high coverage rates of schools translating to one in three schools in the area participating. In contrast, the substantially higher HIV prevalence in pregnant women under 18 years attending antenatal clinics in the region (the HIV prevalence in this population was 18.3% in 2012), highlight that out-of-school adolescent females may be particularly vulnerable to infection and, despite smaller numbers, should not be neglected if school-based prevention efforts are scaled up. Further, this comparison also highlights that maintaining young girls in school and ensuring high school completion is an important structural intervention that should not be under-estimated. In the South African setting, grades 9 and 10 represent a unique point for such an intervention wherein prevention benefits could be maximized, with students in these grades demonstrating sufficient cognitive ability for autonomous decision-making, the majority of students in these grades still being HIV and HSV-2 uninfected and not pregnant, and these grades having comparative numbers of male and female students suggesting relatively low rates of attrition of female students at this stage.

Notwithstanding the limitation of cross-sectional surveys, prevalence estimates and self-reported sexual behavior data, the strong correlation between behavioral findings and the biological measurements of HIV, HSV-2 and pregnancy demonstrate unequivocally that young people in this setting are sexually active and engaging in high risk sexual behavior. The high prevalence of HIV, HSV-2 and pregnancy provide a compelling evidence for targeting and testing both behavioral and biomedical HIV prevention interventions in school-based adolescent populations in high HIV burden settings.

Supplementary Material

1

KEY MESSAGES.

  • South African high school students already bear a substantial burden of HIV, HSV-2 and pregnancy that correlates with high risk sexual behavior

  • Female high school students are at significantly greater risk of HIV and HSV-2 infection compared to male high school students

  • Considerable variability in HIV, HSV-2 and pregnancy is observed between schools

  • Students from child-headed households are particularly vulnerable to HIV infection in generalized epidemic settings with high mortality rates pre-antiretroviral treatment provision

  • There is an urgent need for adolescent-targeted HIV prevention in sub-Saharan Africa

Acknowledgments

We thank all the study staff, the CAPRISA Vulindlela Community Research Support Group, the CAPRISA School Research Support Groups, the Vulindlela community, uMgungundlovu District Education and Health Offices, Provincial Departments of Health and Education, members of Zimnande Zonke, the Vulindlela school circuit management, principals, teachers, Schools Governing Bodies, parents and students for their willingness to contribute to and participate in the study. We thank our funders, MIET Africa for their support.

Funding: Funding for the study was provided by MIET Africa. CAPRISA is part of the Comprehensive International Program of Research on AIDS (CIPRA) and is supported by the National Institute of Allergy and infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS) (grant# 1 U19 AI51794). The career development of ABMK, JF, HH, AG was supported by the Columbia University-Southern African Fogarty AIDS International Training and Research Programme (AITRP) funded by the Fogarty International Center, National Institutes of Health (grant #D43TW00231).

Footnotes

Competing Interests

The authors declare no conflicts of interest.

Author Contributions

QAK, SSAK, HH, NS and AG conceptualized and designed the project. AK, FN, HH, and JF were involved in data collection. QAK, AK, KL, AG, RD and SSAK contributed to data analysis and interpretation. NS coordinated laboratory-based analysis. All authors contributed to either preparation or edits of the final manuscript, and approved revisions.

Publication Statement

The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in STI and any other BMJPGL products and sub-licences such use and exploit all subsidiary rights, as set out in our licence http://group.bmj.com/products/journals/instructions-for-authors/licence-forms”.

References

  • 1.Shisana O, Rehle T, Simbayi LC, et al. South African National HIV Prevalence, Incidence and Behaviour Survey 2012. Cape Town: HSRC Press; 2014. [Google Scholar]
  • 2.South African Department of Health. The 2010 National Antenatal Sentinal HIV and Syphilis Prevalence Survey in South Africa. Pretoria. 2011 Available at: http://www.doh.gov.za/docs/reports/2011/hiv_aids_survey.pdf. (accesssed 23rd October 2013)
  • 3.Abdool Karim Q, Kharsany AB, Frohlich JA, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol. 2011;40(4):922–30. doi: 10.1093/ije/dyq176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kharsany AB, Mlotshwa M, Frohlich JA, et al. HIV prevalence among high school students - opportunities for schools-based HIV testing programmes and sexual reproductive health services. BMC Public Health. 2012;12:231. doi: 10.1186/1471-2458-12-231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rehle T, Shisana O, Pillay V, et al. National HIV incidence measures–new insights into the South African epidemic. SAMJ. 2007;97(3):194–9. [PubMed] [Google Scholar]
  • 6.Abdool Karim Q, Kharsany AB, Frohlich JA, et al. HIV incidence in young girls in KwaZulu-Natal, South Africa–public health imperative for their inclusion in HIV biomedical intervention trials. AIDS Behav. 2012;16(7):1870–6. doi: 10.1007/s10461-012-0209-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Harrison A, Cleland J, Gouws E, et al. Early sexual debut among young men in rural South Africa: heightened vulnerability to sexual risk? Sex Transm Infect. 2005;81(3):259–61. doi: 10.1136/sti.2004.011486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jewkes R, Nduna M, Levin J, et al. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ. 2008;337:a506. doi: 10.1136/bmj.a506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Johnson BT, Scott-Sheldon LA, Huedo-Medina TB, et al. Interventions to reduce sexual risk for human immunodeficiency virus in adolescents: a meta-analysis of trials, 1985–2008. Arch Pediatr Adolesc Med. 2011;165(1):77–84. doi: 10.1001/archpediatrics.2010.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.LoveLife. About LoveLife: a national HIV prevention initiative for young people. Available at: http://www.lovelife.org.za/corporate/about-lovelife/ (accesssed 23rd October 2013)
  • 11.South Africa Department of Health. Impact Assessment: Khomanani Campaign 2007–2009. Available at: http://issuu.com/jacanamedia/docs/khomanani_impact_assessment (accesssed 23rd October 2013)
  • 12.Prinsloo E. Implementation of life orientation programmes in the new curriculum in South African schools: perceptions of principals and life orientation teachers. South African Journal of Education. 2007;27:155–70. [Google Scholar]
  • 13.South Africa Department of Education. National Curriculum Statement Grades 10–12 (General) Life Orientation. Available at: http://www.education.gov.za/LinkClick.aspx?fileticket=xY8RaCOWqTY%3D&.(accesssed 23rd October 2013)
  • 14.Baird SJ, Garfein RS, McIntosh CT, et al. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379(9823):1320–9. doi: 10.1016/S0140-6736(11)61709-1. [DOI] [PubMed] [Google Scholar]
  • 15.Cowan F, Pettifor A. HIV in adolescents in sub-Saharan Africa. Curr Opin HIV AIDS. 2009;4(4):288–93. doi: 10.1097/COH.0b013e32832c7d10. [DOI] [PubMed] [Google Scholar]
  • 16.Cowan FM, Pascoe SJ, Langhaug LF, et al. The Regai Dzive Shiri project: results of a randomized trial of an HIV prevention intervention for youth. AIDS. 2010;24(16):2541–52. doi: 10.1097/QAD.0b013e32833e77c9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Statistics South Africa. General Household Survey 2011. Available at: https://www.statssa.gov.za/publications/P0318/P0318April2012.pdf (accessed 4th April 2014)
  • 18.MacQueen KM, Karim QA. Practice brief: adolescents and HIV clinical trials: ethics, culture, and context. J Assoc Nurses AIDS Care. 2007;18(2):78–82. doi: 10.1016/j.jana.2007.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hogrefe WR, Ernst C, Su X. Efficiency of reconstitution of immunoglobulin g from blood specimens dried on filter paper and utility in herpes simplex virus type-specific serology screening. Clinical and diagnostic laboratory immunology. 2002;9(6):1338–42. doi: 10.1128/CDLI.9.6.1338-1342.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Parliament of South Africa. Children’s Act 2005 (act 38 of 2005) Available at: http://www.justice.gov.za/legislation/acts/2005–038%20childrensact.pdf. (accesssed 23rd October 2013)
  • 21.Hayes RJ, Moulton LH. Cluster Randomised Trials. Chapman & Hall/CRC Interdiscoplinary Statistics. 2009 [Google Scholar]
  • 22.Gouws E, Stanecki KA, Lyerla R, et al. The epidemiology of HIV infection among young people aged 15–24 years in southern Africa. AIDS. 2008;22(Suppl 4):S5–16. doi: 10.1097/01.aids.0000341773.86500.9d. [DOI] [PubMed] [Google Scholar]
  • 23.Pettifor AE, Levandowski BA, MacPhail C, et al. Keep them in school: the importance of education as a protective factor against HIV infection among young South African women. Int J Epidemiol. 2008;37(6):1266–73. doi: 10.1093/ije/dyn131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hargreaves JR, Morison LA, Kim JC, et al. The association between school attendance, HIV infection and sexual behaviour among young people in rural South Africa. J Epidemiol Community Health. 2008;62:113–9. doi: 10.1136/jech.2006.053827. [DOI] [PubMed] [Google Scholar]
  • 25.Panday S, Makiwane M, Ranchod C, et al. Teenage pregnancy in South Africa: with a specific focus on school-going students. Human Sciences Research Council. 2009 Available at: http://www.education.gov.za/LinkClick.aspx?fileticket=uIqj%2BsyyccM%3D& (accesssed 23rd October 2013)
  • 26.Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):435–45. doi: 10.1097/00126334-200404150-00001. [DOI] [PubMed] [Google Scholar]
  • 27.Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science. 2010 Sep 3;329(5996):1168–1174. doi: 10.1126/science.1193748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Karim SS, Karim Q. Effectiveness and safety of vaginal microbicide 1% tenofovir gel for prevention of HIV infection in women. Abstract TUSS0204 presented at the XVIII International AIDS Conference; July 18–23, 2010; Vienna, Austria. [Google Scholar]
  • 29.Pettifor AE, Rees HV, Kleinschmidt I, et al. Young people’s sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS. 2005;19(14):1525–34. doi: 10.1097/01.aids.0000183129.16830.06. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES